| Onym | Funding Scheme | Start Date | End Date | Projects |
| MIBREAST | Win2Wal | 01/01/2021 | 31/12/2024 | Development of a new innovative bioresorbable matrix for breast reconstruction by autologous fat transfer |
| Theramir | BioWIN | 01/04/2021 | 31/03/2025 | Therapeutic approaches based on micro RNA encapsulation |
| Be4ONEW | BioWIN | 01/09/2021 | 31/08/2025 | Biopharmaceuticals for one world |
| NCDVac | SPF | 01/06/2022 | 30/05/2024 | Evaluation of new vaccines and development of appropriate vaccination schedules for Newcastle disease |
| Natexvir | Win4Collective | 01/11/2022 | 31/12/2024 | Implementation and validation of techniques and methods for the preparation of bioactive natural extracts with a view to their valuation as a therapeutic solution against human respiratory viruses |
| GlyPROCLICK | Win4Collective | 01/03/2022 | 29/02/2024 | Modifications of PROtein GLYcans by CLICK reactions with high added value molecules |
| Optymevax | Win4DOC | 27/06/2022 | 27/06/2026 | In silico design and development of optimized versions of key enzymes involved in the production of RNA vaccines |
| NEMO | BioWIN | 01/10/2022 | 30/09/2025 | New-Biological-Entity End-to-end Modeling and Optimization |
| GlycoTool | Win2Wal | 01/01/2023 | 01/01/2025 | GLYcochemistry to control the orientation and immobilization of proteins |
| CoZyme | COST | 01/01/2023 | 31/12/2026 | Establishing a Pan-European Network on Computational Redesign of Enzymes |
| Multichip | Eurostars | 01/05/2023 | 30/04/2026 | Rapid automated multiplex laboratory diagnostics for autoimmune diseases |
| Nowallodor phase 2 | cWALITY | 01/06/2022 | 01/06/2025 | Establish tools and procedures for genomic selection of Walloon Piétrain boars transmitting low risk of boar taint |
| SmartProbiotic | Subside Province Luxembourg | 01/01/2023 | 31/12/2024 | "Smart" probiotics bringing a plus to the level of the health of production animals and making it possible to reduce the use of antibiotics |
| Safety Assessment of Novel Foods and Nutrient Sources | Framework Partn. Agreem. | 01/01/2023 | 31/12/2026 | Support to EFSA in the Safety Assessment of Novel Foods and Nutrient Sources |
| Adekit II | Competitivity Pole | 01/10/2020 | 30/08/2024 | In situ asbestos detection kit in building materials and industry |
| Domibone | cWALITY | 01/01/2021 | 31/12/2024 | Development of a surgical method and an animal model to use the "MyBone" graft in larger bone defects. |
| FoodWal /Peptiboost | Win4Excellence | 01/01/2023 | 31/12/2026 | Bioactive peptides formulated as protein hydrolysates applicable in human and animal health |
| Foodwal / Microboost | Win4Excellence | 01/01/2023 | 31/12/2026 | Enzyme engineering applied to prebiotic synthesis |
| Allerlist | SPF | 01/09/2023 | 31/08/2025 | Valuation de la nécessité d’implémenter de nouveaux allergènes alimentaires d’origine végétale et/ou une nouvelle source de protéines sur la liste des 14 ingrédients causant une allergénicité potentielle |
| Wal-bioimaging | FEDER | 01/07/2023 | 31/12/2025 | Creation of a coordinated network of imaging technology platforms involving universities and accredited research centres. |
| PEPVac | FEDER | 01/07/2023 | 31/12/2025 | Setting up an innovative platform for the preclinical evaluation of new vaccine candidates and risk factors, based on a strengthened partnership between universities and accredited research centres. |
| WalProt | FEDER | 01/09/2023 | 31/12/2025 | Développement de nouvelles pistes de valorisation des protéines végétales et alternatives pour le secteur de l’alimentation humaine |
| Ensured | SPF | 01/09/2023 | 01/01/2026 | NEw opeN Strategy for impUrity suRveillance of commErcial microbial fermentation fooD products: Food supplements and vitamins as proof of concept |
| Phenix | FEDER | 01/11/2023 | 30/10/2025 | Plateformes tecHnologiquEs et aNalytIques d’eXcellence wallonne en agro-alimentaire |
| Passport | Win4Collective | 01/12/2023 | 30/11/2025 | Plasma surface modification of functional implants for more effective tissue regeneration |
| MicroMIC | Win4Collective | 01/01/2024 | 31/12/2025 | Microfluidics for Metabolomics |
| SOLIT | Competitivity Pole | 01/01/2024 | 31/12/2026 | Development of an innovative platform for highly specific tumor suppressive agents delivered by an allogenic cell-derived platform |
| Hybrid-TX | Competitivity Pole | 01/01/2024 | 31/12/2026 | Development of a hybrid approach comprising a viral vector and an mRNA vector for the development of a personalised cancer treatment solution |
